Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epcoritamab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04628494
What this trial is testing

Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
Genmab 483
Testing effectiveness (Phase 2)Looking for participantsNCT06510491
What this trial is testing

Epcoritamab in Previously Treated WM

Who this might be right for
Waldenstrom MacroglobulinemiaB-Cell Lymphoproliferative Disorder
Gottfried von Keudell, MD PhD 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738887
What this trial is testing

Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
The Lymphoma Academic Research Organisation 44
Testing effectiveness (Phase 2)Looking for participantsNCT07218510
What this trial is testing

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
City of Hope Medical Center 33
Early research (Phase 1)Active Not RecruitingNCT05206357
What this trial is testing

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

Who this might be right for
Non-hodgkin Lymphoma
Genmab 17
Large-scale testing (Phase 3)Active Not RecruitingNCT06191744
What this trial is testing

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma

Who this might be right for
Follicular Lymphoma (FL)
Genmab 1,095
Testing effectiveness (Phase 2)Looking for participantsNCT06458439
What this trial is testing

Epcoritamab-CAR T Cells for Large B-cell Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinRelapsed Diffuse Large B Cell LymphomaRefractory Diffuse Large B-cell Lymphoma+2 more
Abramson Cancer Center at Penn Medicine 31
Testing effectiveness (Phase 2)Looking for participantsNCT05783609
What this trial is testing

Epcoritamab and Rituximab for First-line Follicular Lymphoma

Who this might be right for
Follicular LymphomaLow Grade Non-Hodgkin's Lymphoma, Adult
Reid Merryman, MD 100
Testing effectiveness (Phase 2)Looking for participantsNCT05791409
What this trial is testing

Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLL

Who this might be right for
CLL/SLL
Stichting Hemato-Oncologie voor Volwassenen Nederland 112
Testing effectiveness (Phase 2)Active Not RecruitingNCT06112847
What this trial is testing

Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
City of Hope Medical Center 29
Not applicableNo Longer AvailableNCT05692050
What this trial is testing

Expanded Access to Epcoritamab

Who this might be right for
Lymphoma
AbbVie
Testing effectiveness (Phase 2)Active Not RecruitingNCT05451810
What this trial is testing

Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaClassic Follicular Lymphoma
Genmab 184
Testing effectiveness (Phase 2)Looking for participantsNCT07097363
What this trial is testing

Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Non-Hodgkin LymphomaBurkitt LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise Specified+6 more
University of Washington 18
Testing effectiveness (Phase 2)Looking for participantsNCT07197307
What this trial is testing

Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Aggressive Diffuse Large B-cell LymphomaHigh-grade B-cell Lymphoma (HGBL)Follicular Lymphoma (FL) Grade 3B
Universität Münster 120
Testing effectiveness (Phase 2)Looking for participantsNCT06796998
What this trial is testing

Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)

Who this might be right for
Marginal Zone LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueSplenic Marginal Zone Lymphoma+1 more
Izidore Lossos, MD 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07588698
What this trial is testing

Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin's B-cell LymphomaLymphoma Non-HodgkinDiffuse Large B-Cell Lymphoma (DLBCL)
Carrie Ho, MD 20
Testing effectiveness (Phase 2)Looking for participantsNCT05848765
What this trial is testing

Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy

Who this might be right for
Relapsed Follicular LymphomaRefractory Follicular Lymphoma
University of Birmingham 284
Testing effectiveness (Phase 2)Looking for participantsNCT06045247
What this trial is testing

Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Who this might be right for
Large B-cell Lymphoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT06931652
What this trial is testing

Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab

Who this might be right for
Primary CNS Lymphoma (PCNSL)
The Lymphoma Academic Research Organisation 60
Early research (Phase 1)Looking for participantsNCT06447376
What this trial is testing

Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

Who this might be right for
Non-Hodgkin LymphomaCytokine Release Syndrome
Taylor Brooks 20
Next Page